Get started
Author

Raquel Saldaña

Observed name: R Saldaña
ORCID: 0009-0006-1460-0391
Observed ORCID: 0009-0006-1460-0391
OpenAlex ID: A5088474688
Risk factors and outcome of COVID-19 in patients with hematological malignancies
2020 · José Luis Piñana, Rodrigo Martino, et al. · Experimental Hematology and Oncology · 160
PDF
Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial
2016 · Teresa Caballero-Velázquez, Isabel Montero, et al. · Clinical Cancer Research · 44
PDF
To freeze or not to freeze peripheral blood stem cells prior to allogeneic transplantation from matched related donors
2013 · Rocío Parody, Dolores Caballero, et al. · European Journal Of Haematology · 36
Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiency
2019 · Ignacio García-Tuñón, Verónica Alonso-Pérez, et al. · PLoS ONE · 28
PDF
Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group
2020 · Carlos Solano, Lourdes Vázquez, et al. · American Journal of Transplantation · 22
Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality
2024 · Antonio J. Carrascosa, Francisco Navarrete, et al. · International Journal of Molecular Sciences · 17
Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis
2013 · C Fernandez, M C Santos-Silva, et al. · Leukemia · 14
Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft‐versus‐host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group
2021 · Felipe Bueno, Carlos Solano, et al. · Transplant Infectious Disease · 10
Dual Role of the Spinal Endocannabinoid System in Response to Noxious Stimuli: Antinociceptive Pathways and Neuropathic Pain Mechanisms
2025 · Raquel Saldaña, Antonio J. Carrascosa, et al. · International Journal of Molecular Sciences · 8
PDF
CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia
2021 · Elena Vuelta, José Luis Ordoñez, et al. · The CRISPR Journal · 8
Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain
2023 · Anna Torrent, Mireia Morgades, et al. · European Journal Of Haematology · 6
PDF
CRISPR/Cas9 technology abolishes the BCR/ABL1 oncogene in chronic myeloid leukemia and restores normal hematopoiesis
2020 · Elena Vuelta, José Luis Ordoñez, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5
PDF
Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC study
2026 · Marta Peña, Giulia Losi, et al. · Blood Advances · 3
PDF
Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment
2020 · Carlos Solano, Lourdes Vázquez, et al. · Bone Marrow Transplantation · 3
Additive antinociceptive action of intrathecal anandamide reuptake inhibitor and morphine in the management of post-incisional pain in rats
2024 · Antonio J. Carrascosa, María S. García-Gutiérrez, et al. · Biomedicine & Pharmacotherapy · 2
Bispecific T-Cell Engagers for B-Cell NON-Hodgkin Lymphoma Patients before Allogeneic Stem Cell Transplantation. a Study on Behalf Od Geth-TC
2023 · Marta Peña, Jacopo Mariotti, et al. · Blood · 2
Unveiling CMV Risk Signatures After Allogeneic Stem Cell Transplantation Through Machine Learning Approaches: A Multicenter Analysis From the GETH‐TC
2026 · Estela Giménez, Pablo Rodriguez‐Belenguer, et al. · Journal of Medical Virology
Supplementary Figure A1 online only. from Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial
2023 · Teresa Caballero-Velázquez, Isabel Montero, et al.
Supplementary Table 3. Serum levels of cytokines by flow cytometry. from Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial
2023 · Teresa Caballero-Velázquez, Isabel Montero, et al.
Supplementary Table 4. Serum levels of vitamin D. from Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial
2023 · Teresa Caballero-Velázquez, Isabel Montero, et al.
Supplementary Table 1. Toxicity. from Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial
2023 · Teresa Caballero-Velázquez, Isabel Montero, et al.
Supplementary Table 2, online only. Immune recovery after allo-stem cell transplantation from Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial
2023 · Teresa Caballero-Velázquez, Isabel Montero, et al.
Data from Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial
2023 · Teresa Caballero-Velázquez, Isabel Montero, et al.
Results of the Compassionate Program of Inotuzumab Ozogamicin for Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia in Spain
2021 · Josep-Maria Ribera, Olga Garcia, et al. · Blood
Works count: 24
Citation count: 368
H-index: 8
I10-index: 8
Year
Topic
Type